NCT06975085 2026-02-12
Understanding and Addressing Rejection of Personalized Breast Cancer Risk Information: Administrative Supplement Study
University of Colorado, Denver
Phase 2 Completed
Clinical Trials
6 trialsNCT06703593 2025-10-01
Prevention of Doxorubicin-induced Cardiotoxicity in Breast Cancer Patients
British University In Egypt
Phase 2 Completed
NCT03065621 2023-04-19
NeoRHEA
Jules Bordet Institute
Phase 2 Completed
NCT03383679 2022-11-21
START
UNICANCER
Phase 2 Completed
NCT04170465 2022-09-10
METNEO
Damanhour University
Phase 2 Completed
NCT01204125 2017-03-22
SOLTI NEOPARP
Sanofi
Phase 2 Completed